Peer-reviewed veterinary case report
Trifecta Outcomes after Robotic Sacrocolpopexy with Dual Mesh in Single-center Cohort.
By d'Altilia N et al.·2026·Urology Unit, Italy·View original on Europe PMC →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Plain-English summary
This study looked at the results of a specific surgery called robotic-assisted sacrocolpopexy, which is used to treat pelvic organ prolapse in women. It involved 100 patients, mostly around 65 years old, and assessed their outcomes over an average of 18 months after the procedure. The researchers found that only 4% of patients had a significant return of prolapse, 2% developed new urinary incontinence that required further surgery, and 4% experienced major complications. Overall, 90% of the patients had good results, meeting all the key success criteria, indicating that this surgery is both safe and effective for treating pelvic organ prolapse.
Abstract
<h4>Objectives</h4>To evaluate anatomical, functional, and safety outcomes of robotic-assisted sacrocolpopexy (RASC) using a novel trifecta endpoint.<h4>Methods</h4>Single-center study including 100 consecutive patients undergoing RASC between June 2017 and January 2024 at the University of Foggia. Exclusion criteria were follow-up <12 mo, lack of objective evaluation, and preoperative or occult stress urinary incontinence (SUI) on urodynamics. The trifecta outcome was defined as the simultaneous presence of: a) absence of significant pelvic organ prolapse (POP) recurrence, defined as halfway system (HWS) >1 or POP-Q stage >I at follow-up; b) absence of surgery-requiring de novo SUI; c) absence of postoperative major complications, defined as Clavien-Dindo grade ≥II. Outcomes were assessed at routine visits. Continuous variables are reported as median (IQR) and categorical variables as <i>n</i> (%).<h4>Results</h4>Median age was 65 yr (IQR 59-70) and body mass index (BMI) 27 kg/m<sup>2</sup> (25-28); 20% had previous POP surgery. Operative time was 115 min (IQR 91-130), hemoglobin drop 1.1 g/dl, hospital stay 3 d (IQR 2-3). Median follow-up was 18 mo (IQR 13-24). Significant POP recurrence (defined as HWS >1 or POP-Q stage >I) occurred in 4% of patients. Surgery-requiring de novo SUI occurred in 2%. Postoperative major complications (Clavien-Dindo ≥II) occurred in 4%. Overall, 90% of patients simultaneously met all three trifecta criteria.<h4>Conclusions</h4>Robotic-assisted sacrocolpopexy with dual meshes provided stable anatomic outcomes with low rates of surgery-requiring de novo SUI and Clavien-Dindo ≥ II complications. The 90% trifecta supports its safety and effectiveness and suggests its utility as a benchmark in prolapse surgery.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Europe PMC: https://europepmc.org/article/MED/42037645